(858) 587-2510 ext. 201
Raymond Wagenknecht has prosecuted over 100 US Patents in technologies ranging from cardiovascular implants and heart valves to solar wafer fabrication to surgical tools to cell measuring biochips to DNA and RNA analytic methods. In addition, he actively manages international patent portfolios extending into Europe and Asia. By maintaining working relationships with a network of foreign patent attorneys across the globe, he is able to obtain foreign patent protection in many countries at a competitive rate. Raymond's practice also includes analyzing his client's patent portfolios as well as competing patent estates to perform due diligence analysis, to draft freedom to operate opinions and letters of non-infringment. He also acts as co-counsel for patent infringement litigation matters.
Raymond is also an accomplished researcher. He is a contributing author on a number of peer-reviewed scientific publications in the field of immunology and prior to law school worked within both an academic lab within the Department of Medicine at the University of California, San Diego (UCSD) and as part of a research and development team in a San Diego-based biotechnology company.
Raymond received a Bachelor of Science degree in Molecular Biology from the University of California, San Diego (UCSD) and a Juris Doctorate at the University of San Diego, School of Law, where he was elected Vice President of the Science and Technology Law Society.
Among the scientific fields that Raymond has successfully prosecuted patent applications include:
In addition to patents, Raymond helps obtain federal trademarks and represents both plaintiffs and defendants in trademark oppositions.
"A B Cell Superantigen-induced Persistent 'Hole' in the B-1 Repertoire"
G.J. Silverman, S. Cary, D. Dwyer, L. Luo, R. Wagenknecht and V.E. Curtiss.
J. Exp. Med., 2000 Jul 3;192(1):87-98.
"Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface"
Cary SP, Lee J, Wagenknecht R, Silverman GJ
J. Immunol., 2000 May 1;164(9):4730-41
"A B-Cell Superantigen That Targets B-1 Lymphocytes"
Silverman GJ, Cary S, Graille M, Curtiss VE, Wagenknecht R, Luo L, Dwyer D, Goodyear C, Corper AL, Stura EA, Charbonnier JB
Curr Top Microbiol Immunol. 2000;252:251-63
"Improved two-dimensional gel electrophoresis representation of serum proteins using ProtoClear™"
Lollo BA, Harvey S, Liao J, Stevens AC, Wagenknecht R, Sayen R, Whaley J, Sajjadi FG.
Electrophoresis, 1999 Apr-May;20:854-9
“In Vivo Consequences of a B-Cell Superantigen Immunization”
Gregg J. Silverman, Jayakar Nayak, Raymond Wagenknecht, Klaus Warnatz.
Ann. N.Y. Acad. Sci., 1997 Apr 5;815:105-110